Introduction
Hormone secretion from neuroendocrine tissues is a highly regulated process that needs a finely tuned coordination between incoming and output signals. In this regard, adrenal chromaffin cells are remarkable and the study of their secretory machinery 1, 2 and more recently of their synaptic inputs [3] [4] [5] has contributed substantially to the current knowledge on cellular mechanisms underlying neurosecretion function. However, compelling evidence obtained in acute adrenal slices indicate that neurosecretory mechanisms are more intricate than previously envisioned.
Indeed, catecholamine release appears to be dualistically controlled by an incoming initial command assisted by local modulation 6, 7 , supporting the hypothesis of an amplifying system occurring at the chromaffin cell level 8 . The command triggering catecholamine secretion comes from the sympathetic nervous system synapsing onto chromaffin cells. Under basal condition (low splanchnic nerve frequency discharge), acetylcholine (ACh) is the primary neurotransmitter released at the splanchnic nerve terminal-chromaffin synapse. In response to stress or emergency conditions associated with a high nerve frequency firing, a dual splanchnic-adrenal neurotransmission involving both ACh and the pituitary adenylate cyclase-activating polypeptide PACAP occurs 9, 10 , thus enhancing chromaffin cell secretion.
In complement to synaptic transmission, direct communication through gap junctions between chromaffin cells ensures propagation of electrical and ensuing calcium signals between neurosecretory cells and amplifies catecholamine release in response to stimulation of a single cell 11 . The differential regulation of gap junctions and cholinergic synapses c e l l s in physiolological and pathological conditions associated with specific catecholamine demand, such as during early postnatal development 4, 12 and in response to chronic stress 13, 14 , is indicative of a functional interaction between incoming commands and local communication and points towards a putative contribution of gap junctions to stimulus-secretion coupling. Converging arguments have been accumulated that strongly support this hypothesis but the ex vivo acute slice preparation used to obtain them does not allow a convincing demonstration.
We present here a new experimental approach to simultaneously monitor the electrical activity of chromaffin cells and catecholamine secretion in response to splanchnic nerve stimulations in anesthetized adult mice. This in vivo technique is combined with a series of histological and molecular analysis of gap junction protein connexins and of dye diffusion through gap junctions in control, cold stressed and connexin-deficient animals. We demonstrate that adrenal gap junctional signaling contributes positively to catecholamine release in response to splanchnic nerve stimulation in vivo. Furthermore, this contribution is enhanced in stressed animals, providing an additional level of regulation for stimulation-secretion coupling in the adrenal gland.
Results

Electrical activity in the mouse adrenal gland in vivo.
To determine the contribution of gap junctions to stimulus-secretion coupling in anesthetized mice, blood from the left adrenal gland was collected during electrical stimulation of the splanchnic nerve (Figs. 1A and S1; Supplementary Movie 1). The electrical behaviour of the adrenal medullary tissue was monitored using a microelectrode implanted into the adrenal medulla (location identified by injection of Chicago Sky Blue 6B; Supplementary Fig. S2 ). A spontaneous electrical activity was observed ( Fig. 1B , recording duration: 9-22 min, mean frequency 0.87 ± 0.26 Hz (mean ± s.e.m., n = 9 mice)). It consisted of a continuous firing, on which intermittent bursts were superposed in 7/9 mice (1-8 min duration, intra-burst frequency 2.7 ± 1.1 Hz (mean ± s.e.m.)). Tetrodotoxin (TTX, 3 µM) applied locally on the splanchnic nerve induced a marked (89 ± 3.5% (mean ± s.e.m., n = 9 mice)) and partially reversible decrease of the firing activity (Fig. 1C ), indicating that the in 5 vivo spontaneous firing of the mouse adrenal medulla mainly results from excitatory afferent inputs.
Splanchnic nerve stimulation (10 V, 160 ms) triggered a burst of bipolar action potentials occurring specifically during the stimulation (Fig. 1D , upper traces). In the 7 mice recorded, application of 3 µM TTX onto the nerve significantly decreased the evoked activity ( Fig. 1D , middle traces), as illustrated by the decreased variance of the signal. This unambiguously shows that evoked electrical activity in the medullary tissue results from action potentials running along the splanchnic nerve, and not from a direct activation of the gland. In addition, this activity was reversibly inhibited (by 78 ± 12% (mean ± s.e.m., n = 7 mice)), by a local injection of hexamethonium, an antagonist of α3-built nAChRs, through the recording pipette (200 µM, Fig.   1E ). This demonstrates i) the involvement of cholinergic synaptic terminals, as expected for splanchnic nerve-evoked activity and ii) the dominant contribution of nAChRs rather than muscarinic receptors.
Basal and nerve stimulation-evoked catecholamine release. To go further in characterizing excitation-secretion coupling in the adrenal medulla in vivo, we measured catecholamine secretion, at rest and in response to splanchnic nerve stimulation ( Fig. 1A for a schematic illustration of the protocol, Supplementary Fig. S1 and Supplementary Movie 1 for direct visualization). Basal plasma norepinephrine (NE) and epinephrine (E) were assayed in blood samples collected from the left adrenal vein during 2 or 5 min. No statistical difference was observed between catecholamine concentrations measured using the two sampling durations (NE: 15.4 ± 2.9 nM (mean ± s.e.m., n = 11 mice) for 2 min and 25.1 ± 5.2 nM (mean ± s.e.m., n = 17 mice) for 5 min, p>0.05, Mann-Whitney U test; E: 318 ± 111 nM (mean ± s.e.m., n = 11 mice) for 2 min and 384 ± 177 nM (mean ± s.e.m., n = 17 mice) for 5 min, p>0.05, Mann-Whitney U t e s t ). We next examined splanchnic nerve stimulation-evoked catecholamine 6 secretion. Two protocols were used: a low frequency (LF, 0.1 Hz, 5 min) to mimic basal tone firing and a high frequency (HF, 4 Hz, 2 min) to mimic stress firing conditions 15 . Two blood samples were successively collected, a control one first and then a test one during nerve stimulation. In the absence of stimulation, NE and E concentrations in the two successive samples did not significantly differ (NE: C = 36.6 ± 8.5 nM (mean ± s.e.m.) and T = 55.7 ± 22.7 nM (mean ± s.e.m., n = 12 mice), p>0.05, Mann-Whitney U test; E: C = 459 ± 241 nM (mean ± s.e.m.) and T = 500 ± 297 nM (mean ± s.e.m., n= 12 mice), p>0.05, Mann-Whitney U test). Both LF and HF splanchnic nerve stimulations triggered a frequency-dependent release of catecholamines (>2-fold and >10-fold for NE and E, respectively, Fig. 2 ). It is noteworthy that not only basal, but also evoked E release is much larger than NE release. This is consistent with the fact that mouse chromaffin cells mainly exhibit an adrenergic phenotype (80% of epinephrine-containing cells 16 ).
Contribution of gap junctions to catecholamine release. The mouse adrenal medullary tissue
was much more immunoreactive to Cx36 than to Cx43 (Fig. 3A ). The opposite situation was observed in the cortex. Gap junction involvement in nerve stimulation-evoked catecholamine release was determined by blocking junctional coupling. Mice were injected i.p. at the beginning of the surgical procedure with either NaCl (9‰), the uncoupling agent carbenoxolone (CBX, 100 mg/kg) or its inactive structural analog glycyrrhizic acid (GZA, 135 mg/kg). CBX injection significantly reduced gap junctional coupling in the adrenal gland, as evidenced by decreased diffusion of the fluorescent dye Lucifer yellow (LY) measured by scrape-loading 13 (Fig. 3B ). In mice injected with GZA (n = 11) or NaCl (n = 8), LY widely diffused from the cut edge of the gland into the cortex and medulla, while in mice injected with CBX (n = 5), diffusion was greatly decreased and LY accumulated on the cut edge of the medulla (Fig. 3B ). Quantification of LY diffusion into the gland (Figs. 3C and 3D) indicates a reduced (25.8% decrease) diffusion 7 in the depth of the gland in CBX-treated mice. Similarly, CBX treatment (5 mice) reduced by 30 .5% Alexa Fluor 594®-conjugated cadaverine diffusion when compared to GZA (n = 7 mice, p<0.05, Mann-Whitney U t e s t , Fig. 3D and Supplementary Fig. S3 ). These findings unambiguously show the presence of functional gap junctions in the mouse adrenal medullary tissue and demonstrate the efficiency of CBX to block gap junctional coupling in our experimental conditions.
To go further, we performed similar scrape-loading experiments using mefloquine (MFQ), another gap junction uncoupling agent potently active on Cx36-built gap junction channels 17 .
When compared to vehicle (10 glands from 5 mice), MFQ (25 mg/kg) significantly reduced (by 22.7%) LY diffusion throughout the adrenal gland (n = 14 glands from 7 mice, p<0.05, Mann-Whitney U test, Supplementary Fig. S4A -C). It is of note that this percentage is comparable to that obtained in CBX-treated mice ( Fig. 3D ).
Is catecholamine secretion (at rest and in response to splanchnic nerve stimulation) altered when gap junctional communication is reduced? First, basal catecholamine release is significantly higher in mice treated with GZA, CBX, MFQ or its vehicle than in NaCl-injected mice ( Supplementary Fig. S5 ). However, MFQ by itself did not significantly enhance basal catecholamine concentration when compared to its vehicle. Because GZA and CBX have been previously described as hypertensinogenic compounds when infused intra-cerebroventricularly 18 , we investigated whether GZA, CBX and MFQ were able to modify arterial blood pressure under our experimental conditions. Systolic arterial blood pressure (SBP) was measured by tail-cuff plethysmography in anesthetized mice, either not injected (sham) or injected with NaCl, GZA, CBX, vehicle or MFQ. As illustrated in Supplementary Fig. S6 , neither CBX nor GZA increased SBP in our conditions. Conversely, when compared to control values measured before drug injection, CBX, GZA and MFQ decreased SBP, by significant values (Mann-Whitney U test) for CBX (24.6%) and MFQ (27.4%) . This suggests that the increased basal catecholamine secretion measured in the adrenal-venous blood in response to GZA, CBX and MFQ might be a functionally adaptive response to counteract a hypotension-induced stress. It is also of note that none of the injected compounds altered cardiac frequency during the recording period (data not shown).
The contribution of gap junctions to splanchnic nerve stimulation-evoked catecholamine release was addressed by comparing the T/C ratio in CBX-and GZA-injected mice. Indeed, since GZA and CBX affected basal release to the same extent, the action of CBX on nerve stimulationevoked release was measured by comparison with that of GZA. As illustrated in Fig. 4 , CBX decreased both NE and E release evoked by a LF (Fig. 4A ) or HF ( Fig. 4B ) stimulation, although a statistically significant difference was found only for NE release triggered by HF stimulation (58% decrease, n = 9 GZA-and 8 CBX-treated mice, p<0.05, Mann-Whitney U test). Similarly, MFQ trended to decrease HF stimulation-evoked norepinephrine release (47% decrease, n = 5 vehicle-and 9 MFQ-injected mice, p>0.05, Mann-Whitney U test) without affecting epinephrine release ( Supplementary Fig. S4D ). This finding demonstrates that gap junction-mediated intercellular communication in the adrenal gland has a notable contribution to hormone release, at least NE, in vivo.
Increased contribution of gap junctions in stressed mice. We next investigated the effect of CBX in a condition in which gap junctions are increased. The procedure was identical as in our previous work 13, 14 , in which we have demonstrated that a chronic systemic stress (cold exposure) induces a persistent increase in gap junctional coupling between chromaffin cells and upregulates both Cx36 and Cx43 expression in rat. Since the effects of chronic stress may last several hours or days after the end of the stressful stimulus, they can be studied in an animal sacrificed or anaesthetized immediately after return to normal conditions. As illustrated in figure   5A , Cx36 immunostaining in the adrenal medulla was 2-fold higher in cold stressed (n = 6 mice) than in control (n = 5) mice (p<0.05, Mann-Whitney U test). It is noteworthy that expression of Cx43, dominant in the cortex, was not changed by stress ( Supplementary Fig. S7 ). LY diffusion was significantly reduced in CBX-as compared to GZA-injected mice ( Fig. 5B and associated wireframe plots). This reduction (51.2%, Figs. 5C and 5D) is greater than in control mice ( Fig.   3D ). Altogether, these data are consistent with a robust increase of medullary gap junctionmediated cell-to-cell communication in cold stressed mice. Basal plasma NE and E concentrations were surprisingly lower in cold stressed mice than in unstressed mice ( Supplementary Fig. S5 ). However, since these basal concentrations remained similar for CBXand GZA-treatments, contribution of gap junctions to stimulus-secretion coupling could be evaluated by comparing nerve-evoked release after these two treatments. As illustrated in figure   6 , CBX decreased HF stimulation-evoked NE release to a larger extent in cold stressed than in control mice (reduction by 76% in stressed mice, n = 11 animals, as compared to 58% in control mice (n = 11), p<0.05, Mann-Whitney U test). In addition, while CBX did not significantly affect E release in control mice (21% reduction), it reduced dramatically E secretion in cold stressed mice (75% reduction, n = 11 GZA-and 11 CBX-injected animals, p<0.05, Mann-Whitney U test). All together, data obtained in control and cold stressed mice demonstrate i) the contribution of adrenal medullary gap junctions to splanchnic nerve stimulation-evoked catecholamine secretion in vivo and ii) their predominant involvement in stressful situations.
Impaired nerve stimulation-evoked secretion in Cx36 -/mice. Stimulus-secretion coupling
was also investigated in Cx36 deficient (Cx36 -/-) mice. As expected, the transcript encoding Cx36 was robustly expressed in wild-type mice but not detected in Cx36 -/mice, while Cx43 mRNA expression was similar in wild-type and Cx36 -/mice ( Fig. 7A ). Interestingly, the expression of mRNA encoding Cx29, a connexin expressed in S100-positive medullary cells 6 was significantly enhanced in Cx36 -/mice. Expression of Cx36 and Cx43 proteins was also assessed by immunohistofluorescence ( Fig. 7B ). In glands from Cx36 -/mice, Cx36 was detected neither in the cortex nor in the medulla. Cx43 was not detected in the medulla but was expressed in the cortex, at a level comparable to that in control mice (6.7 ± 0.5 AU (mean ± s.e.m., n = 11 glands from 6 mice) for Cx36 -/and 7.5 ± 1.1 AU (mean ± s.e.m., n = 11 glands from 6 mice) for wild type, p>0.05, unpaired Student's t test). Basal catecholamine release was comparable between CBX-and GZA-treated Cx36 -/mice and similar to the basal release in control mice ( Supplementary Fig. S5 ). However, counter to expectations, HF nerve stimulation did not evoke any significant catecholamine release in Cx36 -/mice, whatever the treatment with GZA or CBX ( Fig. 8 ). To try and understand the failure of nerve stimulation to evoke catecholamine release, we tested for integrity of nerve endings and synapses. Nerve terminals were visualized with antibodies against heavy neurofilaments (NF, 200 kDa) to label nerve fibers and against the vesicular acetylcholine transporter (VAChT) to detect synaptic vesicles. As illustrated in Fig. 9A , both NF and VAChT were highly expressed in the control adrenal medulla, decorating the space between lobules and intermingled between individual chromaffin cells within lobules. The staining intensity was significantly attenuated in Cx36 -/mice (n = 21 glands from 11 animals, p<0.05 versus WT, n = 22 glands from 11 mice, unpaired Student's t test,), suggesting an impairment of cholinergic presynaptic terminal function. To further address whether deficits also occurred postsynaptically, expression of mRNA encoding nAChR subunits was evaluated by real-time RT-PCR. None of the 5 tested subunits (α3, α7, α9, β2 and β4) was differentially expressed in Cx36 -/mice when compared to wild-type mice (Fig. 9B ).
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Discussion
Our study reports in vivo basal and splanchnic nerve stimulation-evoked catecholamine secretion from the adrenal gland in anesthetized mouse. In addition, using a combination of in vivo monitoring of adrenal catecholamine secretion and splanchnic nerve stimulation, we shed light on the functional relevance of gap junctions in the adrenal medullary tissue. It becomes now unquestionable that gap junctions contribute positively to nerve-evoked catecholamine release.
A striking observation is that the spontaneous electrical activity in the adrenal medullary tissue in vivo was sporadic and bursting, contrasting with the high frequency firing observed ex vivo 13, 19 or in cultured chromaffin cells [20] [21] [22] . Although our in vivo conditions were designed to minimally disrupt adrenal function, we cannot rule out the possibility that the firing pattern recorded in an anesthetized animal is attenuated. The bursting pattern is likely to be physiologically relevant since catecholamine release from the adrenal is known to be optimized when nerve impulses are delivered in bursts rather than continuously 23,24 . More importantly, we observed that electrical activity was suppressed when action potential propagation along the splanchnic nerve was prevented by TTX. This indicates a predominant nerve-driven activity and a sparse spontaneous electrical firing of chromaffin cells. This finding strengthens the conclusion that chromaffin cell firing discharge is prevailingly paced by synaptic inputs. However, it contrasts with observations made in vitro [25] [26] [27] and ex vivo 13, 19 , in which adrenal chromaffin cells were disconnected from their sympathetic inputs and exhibited a sustained autorhythmic activity 20 supporting robust spontaneous action potential firing. The TTX-sensitivity of in vivo spontaneous activity is in agreement with Petrovic et al. 28 , who demonstrated that spontaneous catecholamine release in an adrenal medulla slice is dramatically decreased by hexamethonium, indicating that release does not result from spontaneous chromaffin cells activity but rather from the commonly observed spontaneous activation of synaptic inputs 4, 5, 12 . The electrical chromaffin cell response to nerveevoked stimulation was also robustly reduced by hexamethonium, supporting a dominant contribution of nAChRs over muscarinic receptors. This corroborates previous findings in mouse acute slices reporting an inhibition of catecholamine release by hexamethonium 28, 29 . However, it contrasts with a study performed in hemisectioned mouse adrenal, in which catecholamine release evoked by acetylcholine mainly depended on muscarinic receptors 19 .
In previous in vivo measurements of basal and stimulated adrenal catecholamine release, E and NE were alternatively assayed from adrenal-venous blood or from the general blood circulation.
In addition, the specie, collection technique and stimulation protocols varied from one study to the other, thus precluding trivial quantitative comparison. Basal and splanchnic nerve stimulation-evoked release of adrenal catecholamines has been directly measured in adrenal venous blood only in a few cases, in the cat 30, 31 , rat 15, 23, 32, 33 , and dog 34, 35 , but not in the mouse.
Our in vivo data indicate a basal E:NE ratio close to 10:1 in mouse. This is consistent with previously reported ratios ranging from 2 to 7 15, 31, [33] [34] [35] . It is noteworthy that it is the opposite when catecholamines are assayed in the plasma, in anesthetized animals 30, 33, 35, 36 , including mouse [37] [38] [39] [40] . In response to electrical splanchnic nerve stimulation (0.1 and 4 Hz), adrenal catecholamine output significantly increased with stimulation frequency. In particular, HF stimulation vigorously enhanced the release of both E and NE, as reported in other species 15, 23, 24, 30, 34 . E and NE can be differentially released from the adrenal, depending on splanchnic nerve stimulation frequency. While NE is the main hormone secreted during LF stimulation (1-5 Hz) in cat 31, 41 , our results in mouse are in favor of a preferential E secretion at both LF and HF stimulation. The same is observed in rat 15 and dog 35 . The stimulation frequencydependent increase in catecholamines is a robust event, since it also occurs in acute adrenal slices 42 . In cold stressed mice, basal catecholamine concentration in adrenal-venous blood was 13 unexpectedly lower than in control mice. This mismatches with previous data reporting a rise in catecholamine concentration in the adrenal vein in response to various stressors 33, 36, 43 . This also contrasts with the typical in vivo increase in catecholamine concentrations measured in plasma, in response to stressful situations 33, 36, 40, 44 . However, the situation in the adrenal-venous blood appears more intricate, such that a robust catecholamine increase detected in plasma is not always associated with equally vigorous catecholamine amounts flowed from the adrenal 44 . The low basal catecholamine concentration we found here was unlikely due to depletion of adrenal catecholamine resources, since the gland further secreted in response to nerve stimulation.
Alternatively, the anesthesia and surgical procedure may have uncontrolled consequences on the basal release. Although ketamine does not modify basal catecholamine secretion 45 , a direct measurement of plasma catecholamines, in a freely moving mouse submitted or not to various stress paradigms, will be necessary to definitely answer this question.
Even though a direct cell-cell communication through gap junctions has been described in many endocrine/neuroendocrine tissues [46] [47] [48] [49] , including the adrenal medulla 6,7,11 , its contribution to hormone secretion in vivo has been unambiguously established so far only for insulin 50, 51 and renin 49, 52 . Very recent studies performed in the anterior pituitary 53,54 strongly support a crucial role for gap junctions in endocrine tissue output, suggesting that the plasticity of gap junctioncoupled endocrine cell network is a key element underlying functional adaptation of hormone release at the population level. More remarkable is the observation that functional adaptation to specific hormonal demand persists within the coupled network 55 . If transposed to the chromaffin cell network, this could be particularly relevant in terms of functional tissue adaptation in response to repeated stressful conditions. Regarding the adrenal gland, contribution of gap junctions to stimulation-secretion coupling was previously inferred from in situ experiments in rodent adrenal acute slices 11, 56 . Conversely, Petrovic et al. 28 Supplementary Fig. S1 and Supplementary Movie 1).
Blood collection and catecholamine assay. Twenty minutes after surgery, two blood samples
were successively collected during 2 or 5 min each, depending on the stimulation protocol, one control first (C) and then a test one (T) during stimulation. Stimulation-evoked catecholamine release was expressed as the T/C ratio. Samples were centrifugated at 4°C (7000 g, 10 min) and stored at -20°C until use. Catecholamines (epinephrine and norepinephrine) were assayed from 7 µl of plasma using a 2-CAT ELISA KIT (Mediane Diagnostics, Plaisir, France), as reported 63 .
Arterial blood pressure measurement. Systolic blood pressure (SBP) was measured by tailcuff plethysmography (BP-2000 blood pressure analysis system, Visitech Systems, Bioseb, Chaville, France) in ketamine/xylazine anesthetized mice. Mice were introduced into a restraint device with the blood pressure measure cuff placed on the base of the tail. The thermal heating pad underneath was set to 30°C. SBP and cardiac frequency were monitored every minute for 60 min (15 min as a control period before injection and up to 40-45 min after injection as the test period), to reliably compare the results with adrenal-venous blood catecholamine levels assayed 40-50 min after drug injection).
Electrophysiology. Square electrical pulses (10 V, 160 ms) were applied to the nerve at low (0.1 Hz, 5 min) or high frequency (4 Hz, 2 min). To block nerve conduction, a tetrodotoxin (TTX)-soaked cotton bud (3 µM) was applied on the nerve, as far as possible (2-3 mm) from the gland. Extracellular recordings were performed with a glass microelectrode (in mM: 150 NaCl, 12.5 KCl, 10 HEPES, pH 7.4). The recording site was located by injection of Chicago Sky Blue 6B (2%, Supplementary Fig. S2 ). In some experiments, the recording electrode contained hexamethonium (200 µM) to impair cholinergic neurotransmission.
In vivo blockade of gap junctions. Mice were injected i.p. (120 µl NaCl 9‰) before the surgical procedure with either carbenoxolone 64 (CBX, 100 mg/kg) or its inactive analog glycyrrhizic acid 65 Scrape-loading dye transfer. In vivo surgery and pharmacological treatments were identical to those described above. Excised glands were included in agarose, cooled on ice, hemisectioned and incubated for 45 s either in Lucifer yellow (LY, lithium salt; 0.2% in NaCl 9‰, charge -2/MW 457) or Cadaverine (Alexa Fluor 594®-conjugated, 50 µM in NaCl 9‰, charge +1/MW 807) 66 . Hemi-glands were immediately fixed in PFA (4% in 0.1 M phosphate buffer) and stored at 4°C. Hemi-glands were sliced (50 µm) and imaged with an epifluorescence microscope and the ImageJ software. Average light intensity was measured in the adrenal medulla, along an axis perpendicular to the cutting edge (distance = 0 at the edge and increasing with penetration into the medulla), leading to a "fluorescence versus distance" curve. Results were further expressed as the area under the curve for statistical analysis. 
